Accelerated partial breast irradiation using once-daily fractionation: analysis of 312 cases with four years median follow-up
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Accelerated partial breast irradiation using once-daily fractionation: analysis of 312 cases with four years median follow-up ; volume:7 ; number:1 ; day:6 ; month:2 ; year:2012 ; pages:1-8 ; date:12.2012
Radiation oncology ; 7, Heft 1 (6.2.2012), 1-8, 12.2012
- Creator
-
Shaikh, Arif Y.
- Contributor
-
LaCombe, Michael A.
Du, Hongyan
Raghavan, Vathsala T.
Nanda, Ranjeev K.
Bloomer, William D.
SpringerLink (Online service)
- DOI
-
10.1186/1748-717X-7-17
- URN
-
urn:nbn:de:1111-2016072617186
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shaikh, Arif Y.
- LaCombe, Michael A.
- Du, Hongyan
- Raghavan, Vathsala T.
- Nanda, Ranjeev K.
- Bloomer, William D.
- SpringerLink (Online service)
Other Objects (12)
Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
O413 Pharmacokinetics (PK) of once-daily etravirine (ETR) without and with once-daily darunavir/ritonavir (DRV/r) in antiretroviral-naïve HIV-1 infected adults
Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation
Once-daily regimens were associated with a higher rate of self-chosen discontinuations
Use of once-daily raltegravir-based HAART in HIV-infected injection drug users
The use of a darunavir/ritonavir once-daily regimen in two pregnant women
Population pharmacokinetic modelling of once-daily ritonavir-boosted darunavir in HIV-infected patients
Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets
Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy
Population Pharmacokinetics and Pharmacodynamics of Once-Daily Growth Hormone Norditropin® in Children and Adults
Once-Daily Triple Therapy in Patients with COPD: Patient-Reported Symptoms and Quality of Life
Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma
Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
O413 Pharmacokinetics (PK) of once-daily etravirine (ETR) without and with once-daily darunavir/ritonavir (DRV/r) in antiretroviral-naïve HIV-1 infected adults
Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation
Once-daily regimens were associated with a higher rate of self-chosen discontinuations
Use of once-daily raltegravir-based HAART in HIV-infected injection drug users
The use of a darunavir/ritonavir once-daily regimen in two pregnant women
Population pharmacokinetic modelling of once-daily ritonavir-boosted darunavir in HIV-infected patients
Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets
Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy
Population Pharmacokinetics and Pharmacodynamics of Once-Daily Growth Hormone Norditropin® in Children and Adults
Once-Daily Triple Therapy in Patients with COPD: Patient-Reported Symptoms and Quality of Life
Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma
Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
O413 Pharmacokinetics (PK) of once-daily etravirine (ETR) without and with once-daily darunavir/ritonavir (DRV/r) in antiretroviral-naïve HIV-1 infected adults
Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation
Once-daily regimens were associated with a higher rate of self-chosen discontinuations
Use of once-daily raltegravir-based HAART in HIV-infected injection drug users
The use of a darunavir/ritonavir once-daily regimen in two pregnant women
Population pharmacokinetic modelling of once-daily ritonavir-boosted darunavir in HIV-infected patients
Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets
Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy
Population Pharmacokinetics and Pharmacodynamics of Once-Daily Growth Hormone Norditropin® in Children and Adults
Once-Daily Triple Therapy in Patients with COPD: Patient-Reported Symptoms and Quality of Life